Today

Agents

Chat

Arena

Discover

More

App

Bernstein raises Vertex Pharmaceuticals target price to $620 from $608

VRTX•2026-11-05

Bernstein raised its target price for Vertex Pharmaceuticals to $620 from $608.

Related News

B

Dream Finders Homes receives tenders for $641.19 million of Beazer notes in debt exchange

BZH•2026-11-05

C4 Therapeutics Q3 2026 net loss narrows 32% year over year to $21.84 million

CCCC•2026-11-05

Canada Goose Q2 revenue CAD 274 million vs. IBES estimate CAD 278.9 million

GOOS•2026-11-05

Kimbell Royalty Partners Q3 net income falls 23% year over year to $17.25 million

KRP•2026-11-05

Aya Gold & Silver agrees to sell Azegour project to Sama Resources for shares

AYA•2026-11-05

Bernstein raises Vertex Pharmaceuticals target price to $620 from $608 - VRTX News | Rallies